Infinity Chem Launches U.S-Manufactured Peptide Platform To Redefine Research-Grade Quality And Supply Chain Transparency

December 14, 2025 6:15 AM

Infinity Chem, operating through its website at https://8chem.com, today announced the formal launch of its U.S-manufactured peptide program, built around domestic synthesis, sterile packing, and analytics in a single Scottsdale, Arizona facility. Designed for laboratories that want research supplies made and conditioned in the United States, the Infinity Chem platform gives investigators a direct line of sight from targeted peptide sequence to...

Read more

President Trump's Cannabis Decision Is Coming - And Why MMJ International Holdings Wins Either Way

December 13, 2025 2:15 PM

As President Donald Trump prepares to announce a landmark decision on the federal classification of cannabis, MMJ International Holdings today affirmed its strategic position, asserting that its unique, seven year focus on FDA regulated drug development guarantees a win regardless of whether the final decision is rescheduling, delay, or stricter federal enforcement. The Legal Illusion: Announcement Does Not Mean Instant LawMMJ stressed that...

Read more

Sugar Defender Reviews (2025 Clinical Report) Evidence, Metabolic Research, Complaints & Real Outcomes After 90 Days

December 13, 2025 12:10 PM

The surge in search volume for Sugar Defender over the first half of 2025 is not an accident. Metabolic health is collapsing globally, and millions are looking for solutions that address glucose volatility, cravings, fatigue, and insulin resistance without the side effects tied to pharmaceuticals. But while the conversation around natural blood sugar formulas exploded last year, the renewed interest in The Original Sugar Defender comes from...

Read more

Prostadine Reviews (EXPERT ANALYSIS 2026) New Data on Hard-Water Toxicity, Urinary Flow Support & Real Complaint Patterns

December 13, 2025 6:05 AM

Prostate-health searches surged sharply in early 2025, driven by growing concern around urinary flow decline, hard-water mineral exposure, inflammation, and toxic-load buildup in aging men. Prostadine is now one of the most discussed natural formulas in this category, not because of hype, but because men over 40 are actively looking for non-drug support that feels medically plausible, safe, and rooted in mechanism rather than marketing. Our...

Read more

Zealthy Review 2026: How Zealthy Compares to FitRx and RoenRx for Weight Loss & GLP-1 Care

December 12, 2025 5:20 PM

The landscape of weight management has undergone a seismic shift. Zealthy is one of the fastest-growing telehealth weight-loss platforms in the U.S., offering access to GLP-1 medications, insurance support, and personalized coaching. Many people searching for ‘Zealthy' want to understand what makes the company different, how it works, and whether it's a better option than competitors. This guide breaks down exactly how Zealthy compares to FitRx...

Read more

Aspire Biopharma Granted Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements

December 12, 2025 5:00 PM

Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), a developer of a multi-faceted patent-pending drug delivery technology, received notice (the "Notice") on December 11, 2025, from the Nasdaq Listing Qualifications Panel (the "Hearings Panel") of The Nasdaq Stock Market LLC ("Nasdaq") that the Hearings Panel has granted the Company's request to continue its listing on The Nasdaq Stock Market, subject to the Company...

Read more

VSee Health, Inc. Announces Postponement of Annual Meeting of Stockholders Until December 30, 2025

December 12, 2025 4:30 PM

VSee Health, Inc. (NASDAQ:VSEE) a leader in innovative telemedicine solutions, today announced that it anticipates that it will not have a sufficient number of shares of the Company's common stock present in person or represented by proxy at the 2025 Annual Meeting of Stockholders (the "Annual Meeting"), scheduled for Monday, December 15, 2025 at 2:30 p.m. Eastern Time, to constitute a quorum. The Company has decided to postpone the Annual...

Read more

Cadrenal's Quiet Expansion Play Is Starting to Get Loud

December 12, 2025 11:00 AM

Cadrenal Therapeutics (NASDAQ:CVKD) entered the back half of the year with a calm, almost surgical approach to building out its foundation. While most microcaps lean on noise to stay visible, Cadrenal has let its work do the lifting. Trial preparation moved forward. Manufacturing advanced. Leadership depth expanded inside the clinical ranks. None of it screamed for attention, but each decision made the Company harder to ignore. Quiet progress is...

Read more

Cadrenal's Anticoagulation Platform Is Expanding in a $40 Billion Market

December 12, 2025 9:45 AM

Cadrenal Therapeutics (NASDAQ:CVKD) believes it continues to be misread by the market. Yes, the Company is intentionally narrowly focused. However, the lane it occupies is among the most undertreated areas in medicine. Anticoagulation for difficult-to-treat patients has not seen meaningful reinvention in decades. Warfarin persists due to a lack of innovation. DOACs dominate because alternatives have not evolved. Cadrenal is stepping into that...

Read more

VSee Health, Inc. Regains Compliance with Nasdaq Stockholders' Equity Requirement

December 12, 2025 8:00 AM

VSee Health, Inc. (Nasdaq:VSEE, VSEEW), a leading provider of telehealth and digital health solutions, today announced that it has regained compliance with Nasdaq Listing Rule 5550(b)(1) (the "Minimum Equity Rule").As previously disclosed, on September 2, 2025, the Company received notice from Nasdaq that its stockholders' equity had fallen below the $2.5 million minimum required for continued listing on The Nasdaq Capital Market. Following a...

Read more

Agape ATP Corporation Issues Statement on Recent Market Activity and Reaffirms Strategic Outlook

December 12, 2025 4:10 AM

Agape ATP Corporation (NASDAQ:ATPC) ("ATPC" or "the Company") a provider of health and wellness products and sustainable energy solutions, today issued a statement addressing recent volatility in the trading price of its common stock.The Company confirms that its business operations continue as usual. Management is not aware of any material, undisclosed corporate developments or adverse operating conditions that would explain the recent...

Read more

Biotech R&D Growth and the Expanding Research Peptide Market

December 12, 2025 2:30 AM

From 2024 to 2027, biotech R&D growth is increasingly shaped by a quiet enabler: high-purity research peptides. As labs pursue complex work in regenerative biology and molecular signaling, they rely on specialized peptide tools rather than generic reagents. TB-500, supplied strictly as a research-only peptide, highlights how advanced materials now sit at the core of modern experimental design.This article looks at the macro picture. It explores...

Read more

CLn Skin Care Wins 2025 Beauty Innovation Award for Hand Product of the Year

December 11, 2025 5:05 PM

CLn Skin Care, a leader in dermatologist-developed therapeutic skincare, is proud to announce that its CLn HandWash has been named "Hand Product of the Year" in the 2025 Beauty Innovation Awards.CLn HandWash Wins Hand Product of the Year (2025) CLn HandWash, a dermatologist-developed, fragrance-free hand cleanser for sensitive skin, named "Hand Product of the Year" in the 2025 Beauty Innovation Awards. Selected from thousands of global...

Read more

Exousia Pro, Inc. Announces Executed LOI for Strategic Acquisition of High-Revenue Telehealth Platform to Accelerate Nutraceutical Commercialization

December 11, 2025 12:15 PM

Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company focused on proprietary exosome-based delivery systems, is excited to announce that it has executed a Letter of Intent to acquire a high-growth, established telehealth organization. Once acquired the Telehealth Platform will operate under Exousia Pro's newly-formed subsidiary, Exousia Health, Inc.This strategic transaction is designed to immediately generate substantial...

Read more

HomeAid Celebrates the Launch of Its 20th Affiliate in the Delaware Valley Area

December 11, 2025 12:00 PM

HomeAid, a national nonprofit organization dedicated to ending homelessness in the United States, is proud to announce the launch of its 20th affiliate in the Delaware Valley area. This affiliate will serve individuals experiencing or at risk of homelessness in southeastern Pennsylvania, southern New Jersey, northern Delaware, and a small part of Maryland. This expansion is a significant milestone for HomeAid, reflecting its deep commitment to...

Read more

LIV Recovery Center Expands Family Care & Support to Address Hidden Impact of Addiction

December 11, 2025 11:00 AM

LIV Recovery Center has launched a comprehensive Family Care & Support program designed to help loved ones navigate the complexities of addiction while prioritizing their own mental health and well-being. The Alpharetta-based behavioral health facility recognizes that addiction affects entire family systems, not just individuals struggling with substance use disorders.The program centers on Al-Anon's "3 Cs" framework, "You didn't Cause it, you...

Read more

Birdsong Health Literacy Center of Excellence and EdLogics Selected by Primary Health Solutions to Advance Substance Use Education in Schools across Southwest Ohio

December 11, 2025 10:40 AM

The Birdsong Health Literacy Center of Excellence (Birdsong HLCOE) and EdLogics are proud to announce their selection by Primary Health Solutions (PHS) to support a major new initiative designed to enhance substance use education and prevention for students across Southwest Ohio. Enabled by PHS's recent grant from the Substance Abuse and Mental Health Services Administration (SAMHSA), the collaboration will integrate the Rewards for Healthy...

Read more

DrHouse Launches Complete Virtual Care in Dallas-Fort Worth With 1-Hour Prescription Delivery

December 11, 2025 10:00 AM

A major shift in healthcare access arrives in the Greater Dallas area as DrHouse launches its complete virtual healthcare service. Bringing together telehealth consultations, online doctor visits, and fast medication delivery into a single, frictionless care experience.The rollout gives Dallas-Fort Worth residents access to virtual urgent care, diagnosis, and treatment, from video-call consultation to doorstep delivery without needing to travel...

Read more

Tivic Acquires Ready-to-Scale cGMP Manufacturing and Development Assets to Accelerate Commercialization of Entolimod; Tivic Growth Backed By $90M+ Financing Package

December 11, 2025 9:45 AM

Tivic Health® Systems, Inc. (Nasdaq:TIVC), a diversified therapeutics company, today announced it has acquired the strategic manufacturing and development assets of Scorpius Holdings, Inc. and is launching Velocity Bioworks™, a wholly owned subsidiary of Tivic, to provide contract development and manufacturing services to Tivic and other companies.Strategic advantages of this acquisition and the formation of Velocity Bioworks include:Secures a...

Read more

Medical Care Technologies Inc. (OTC Pink:MDCE) to Launch Apps Through iHeartRadio's Network, Leveraging 270 Million Monthly Listeners

December 11, 2025 9:30 AM

Medical Care Technologies Inc. (OTC Pink:MDCE) is pleased to announce a new strategic marketing partnership with iHeartRadio, the leading audio media company in America. This collaboration will harness iHeartRadio's extensive network of radio stations, podcasts, and digital channels to promote MDCE's upcoming health and wellness applications to a broad and diverse audience. With a reach of over 270 million monthly listeners, iHeartRadio stands...

Read more